Yale Cancer Center

This account is verified. Learn more

@YaleCancer

Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.

New Haven, Connecticut yalecancercenter.org Joined September 2012

1.8K Following 17K Followers 10K Posts

Latest posts 5

Yale Cancer Center @YaleCancer 8h

.@jennkwanMDPhD will present two posters this weekend at @AHAScience #ScientificSessions26 on the topics of:
➡️Single-cell mapping → steroid-resistant ICI myocarditis
➡️Female predominant JAK-STAT signaling → sex-tailored cardioprotection
@SmilowCancer @YaleCardiology

Yale Cancer Center @YaleCancer 9h

This afternoon at @AHAScience #ScientificSessions26, Dr. Jiarui Xing presents a digital poster on "Sex-Specific Anteroseptal Fibrotic Signatures on LGE-CMR Predict Future Cardiomyopathy in Cardio-Oncology."
@SmilowCancer @jennkwanMDPhD @YaleCardiology @Halene_lab

Yale Cancer Center @YaleCancer 1d

“For a young person, when they get a #BRAF mutation, that is extremely likely to lead to #melanoma. But for an older person, it's less likely, though still possible,” @JeffTownsend. “This is important because there are therapies that target BRAF. It suggests they could be less effective in older patients than in younger ones.”
medicine.yale.edu/cancer/news-ar…
@SmilowCancer @ScienceAdvances @YaleSPH @OncoAlert

medicine.yale.edu Patient Age Could Be Key to Precision Medicine for Melanoma New Yale research finds that different mutations are favored by natural selection in melanoma from patients of different ages, providing insights for future

Yale Cancer Center @YaleCancer 1d

A study led by @loraygs finds mortality and #frailty increase the longer an older adult remains in the hospital after surgery for non-metastatic pancreatic ductal adenocarcinoma #PDAC.
medicine.yale.edu/publication-de…
@SmilowCancer @YaleGICancers @YaleCOPPER @ysphbiostat @cpgYALE @JGeriOnc

medicine.yale.edu Frailty Linked to Home Time Loss After Pancreatic Surgery This study shows that frailty strongly predicts days lost outside the hospital after pancreatic cancer surgery in older adults.

Yale Cancer Center @YaleCancer 2d

The #FDA granted accelerated approval of amivantamab and hyaluronidase-lpuj for patients with recurrent or metastatic head and neck squamous cell carcinoma #HNSCC. An exciting development for patients and we congratulate Dr. Barbara Burtness on her work and leadership in the field!
➡️bit.ly/4iIrWpv
@SmilowCancer @YNHH